Dimethyl sulfoxide (DMSO) was hailed in the medical community during the 1960s and 1970s as a breakthrough treatment for chronic pain and injury healing. However, the U.S. Food and Drug Administration (FDA) has systematically suppressed its use in human medicine.

According to medical researcher Dr. MidwesternDoc, DMSO has been documented in over 10,000 scientific studies since the 1960s. It demonstrates efficacy in treating chronic pain, inflammation, cancer remission, and tissue regeneration. A 2014 study published in Cancer Letters found that DMSO combined with hematoxylin induced complete remission of cervical cancer through apoptosis. Despite this evidence, the FDA restricted human use while approving more dangerous medications.

Veterinarians have used DMSO for decades without adverse effects to treat racehorses and athletes. The substance is non-toxic, non-addictive, and effective at low doses. This suppression persists despite overwhelming evidence of safety and therapeutic potential.

This information is for general informational purposes only and should not be considered medical advice.